84 related articles for article (PubMed ID: 22193445)
1. [Suppressing poly(ADP-ribose)polymerase-1 inhibits tau phosphorylation in HEK293/tau441 cells].
Chen QH; Liao XM; Wang SH
Sheng Li Xue Bao; 2011 Dec; 63(6):511-6. PubMed ID: 22193445
[TBL] [Abstract][Full Text] [Related]
2. GSK-3beta and oxidative stress in aged brain. Role of poly(ADP- -ribose) polymerase-1.
Songin M; Jeśko H; Czapski G; Adamczyk A; Strosznajder RP
Folia Neuropathol; 2007; 45(4):220-9. PubMed ID: 18176896
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) polymerase inhibitor is neuroprotective in epileptic rat via apoptosis-inducing factor and Akt signaling.
Wang SJ; Wang SH; Song ZF; Liu XW; Wang R; Chi ZF
Neuroreport; 2007 Aug; 18(12):1285-9. PubMed ID: 17632284
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of GSK-3β by calpain counteracts the inhibitory effect of Ser9 phosphorylation on GSK-3β activity induced by H₂O₂.
Feng Y; Xia Y; Yu G; Shu X; Ge H; Zeng K; Wang J; Wang X
J Neurochem; 2013 Jul; 126(2):234-42. PubMed ID: 23646926
[TBL] [Abstract][Full Text] [Related]
5. Effect of acute poly(ADP-ribose) polymerase inhibition by 3-AB on blood-brain barrier permeability and edema formation after focal traumatic brain injury in rats.
Lescot T; Fulla-Oller L; Palmier B; Po C; Beziaud T; Puybasset L; Plotkine M; Gillet B; Meric P; Marchand-Leroux C
J Neurotrauma; 2010 Jun; 27(6):1069-79. PubMed ID: 20380552
[TBL] [Abstract][Full Text] [Related]
6. Poly (ADP-ribose) polymerase-1 inhibitor, 3-aminobenzamide pretreatment ameliorates lipopolysaccharide-induced neurobehavioral and neurochemical anomalies in mice.
Sriram CS; Jangra A; Gurjar SS; Hussain MI; Borah P; Lahkar M; Mohan P; Bezbaruah BK
Pharmacol Biochem Behav; 2015 Jun; 133():83-91. PubMed ID: 25863272
[TBL] [Abstract][Full Text] [Related]
7. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
[TBL] [Abstract][Full Text] [Related]
8. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
Palfi A; Toth A; Hanto K; Deres P; Szabados E; Szereday Z; Kulcsar G; Kalai T; Hideg K; Gallyas F; Sumegi B; Toth K; Halmosi R
J Mol Cell Cardiol; 2006 Jul; 41(1):149-59. PubMed ID: 16716347
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the binding characteristics to and inhibitory potencies towards PARP and in vivo antidiabetogenic potencies of taurine, 3-aminobenzamide and nicotinamide.
Pandya KG; Patel MR; Lau-Cam CA
J Biomed Sci; 2010 Aug; 17 Suppl 1(Suppl 1):S16. PubMed ID: 20804590
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase inhibition improves erectile function by activation of nitric oxide/cyclic guanosine monophosphate pathway in diabetic rats.
Li WJ; Peng Y; Zhou J; Li B; Wang H; Zhang J; Wang Z
J Sex Med; 2012 May; 9(5):1319-27. PubMed ID: 22429732
[TBL] [Abstract][Full Text] [Related]
11. The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals.
Koh SH; Park Y; Song CW; Kim JG; Kim K; Kim J; Kim MH; Lee SR; Kim DW; Yu HJ; Chang DI; Hwang SJ; Kim SH
Eur J Neurosci; 2004 Sep; 20(6):1461-72. PubMed ID: 15355313
[TBL] [Abstract][Full Text] [Related]
12. PARP inhibition restores erectile function by suppressing corporal smooth muscle apoptosis in diabetic rats.
Li WJ; Zhou J; Li B; Wang H; Peng YB; Wang Z
J Sex Med; 2011 Apr; 8(4):1072-82. PubMed ID: 21235725
[TBL] [Abstract][Full Text] [Related]
13. Poly (ADP-ribose) polymerase (PARP) is essential for sulfur mustard-induced DNA damage repair, but has no role in DNA ligase activation.
Bhat KR; Benton BJ; Ray R
J Appl Toxicol; 2006; 26(5):452-7. PubMed ID: 16906506
[TBL] [Abstract][Full Text] [Related]
14. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
[TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase-3beta activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells.
Lee KY; Koh SH; Noh MY; Park KW; Lee YJ; Kim SH
Brain Res; 2007 Jan; 1129(1):89-99. PubMed ID: 17157278
[TBL] [Abstract][Full Text] [Related]
16. Increased poly(ADP-ribosyl)ation in peripheral leukocytes and the reperfused myocardium tissue of rats with ischemia/reperfusion injury: prevention by 3-aminobenzamide treatment.
Zhang LQ; Qi GX; Jiang DM; Tian W; Zou JL
Shock; 2012 May; 37(5):492-500. PubMed ID: 22266967
[TBL] [Abstract][Full Text] [Related]
17. Effects of 3-aminobenzamide on expressions of poly (ADP ribose) polymerase and apoptosis inducing factor in cardiomyocytes of rats with acute myocardial infarction.
Zhao YJ; Wang JH; Fu B; Ma MX; Li BX; Huang Q; Yang BF
Chin Med J (Engl); 2009 Jun; 122(11):1322-7. PubMed ID: 19567145
[TBL] [Abstract][Full Text] [Related]
18. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
Kuo ML; Shen SC; Yang CH; Chuang SE; Cheng AL; Huang TS
Oncogene; 1998 Oct; 17(17):2225-34. PubMed ID: 9811453
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose)polymerase activation mediates lung epithelial cell death in vitro but is not essential in hyperoxia-induced lung injury.
Pagano A; Pitteloud C; Reverdin C; Métrailler-Ruchonnet I; Donati Y; Barazzone Argiroffo C
Am J Respir Cell Mol Biol; 2005 Dec; 33(6):555-64. PubMed ID: 16151053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
